Infectious Disease Control

Outlook for Hepatitis Patients Set to Improve with Development of Accessible Treatments

PHILADELPHIA, July 28, 2014 /PRNewswire/ -- The Intellectual Property and Science Business of Thomson Reuters , the world's leading source of intelligent information for businesses and professionals, today released a new study in recognition of World Hepatit...

2014-07-28 21:09 1579

Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results

BEIJING, July 25, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the second quarter ended June 30, 2014, after market close on Thursday, August 14, 2014 EDT. ...

2014-07-25 17:00 1456

Founding of WAIDID, the World Association for Infectious Diseases and Immunological Disorders Unveiled at the Infectious Diseases World Summit Shanghai 5-6 July 2014

MILAN, July 7, 2014 /PRNewswire/ -- WAIDID, the new International Scientific Society  presided over by Prof. Susanna Esposito, has the objective of promoting scientific research and the dissemination of information on infectious and immunological diseases on both the national and international ...

2014-07-07 17:55 1785

International Vaccine Institute Launches New Video Marketing Campaign, "Choose Your World"

SEOUL, South Korea, July 2, 2014 /PRNewswire/ -- The International Vaccine Institute (IVI) unveiled today a new integrated video marketing campaign, "Choose Your World," promoting awareness and encouraging grassroots fundraising to support the organization's initiatives. The campaign features a 3-mi...

2014-07-02 12:37 3345

BD Launches New Point-of-Care System for HIV/AIDS Patients

-- Easy-to-use CD4 analysis platform tailored to meet the needs of resource-limited settings SAN JOSE, Calif., May 6, 2014 /PRNewswire/ -- BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD...

2014-05-06 09:00 1142

FDA Approves Ibalizumab Manufactured by WuXi PharmaTech for Treatment of Patients on Expanded Access

SHANGHAI and TAIPEI, May 5, 2014 /PRNewswire/ -- WuXi PharmaTech (NYSE: WX) and TaiMed Biologics today announced that the FDA has approved the first batch of the ibalizumab (TMB-355) drug substance and sterile drug product manufactured at WuXi's biologics facilities for ongoing treatment of patients...

2014-05-05 20:00 1248

bioCSL supports public health efforts in Laos with donation of more than 700,000 doses of seasonal influenza vaccine

-- Participation in innovative public-private collaboration helps improve vaccination infrastructure, expand patient reach in partner countries KING OF PRUSSIA, Pa., April 29, 2014 /PRNewswire/ -- bioCSL, formerly CSL Biotherapies, has announced the donation of more than 700,000 doses of its influe...

2014-04-29 01:23 2439

Thomson Reuters Study Shows Potential Malaria Vaccine on Horizon as Global Climate Change Threatens to Increase World Incidence Rate

- New analysis in support of World Malaria Day reveals key advances and challenges in malaria research PHILADELPHIA, April 25, 2014 /PRNewswire/ -- In recognition of World Malaria Day, the Intellectual Property & Science business of Thomson Reuters( http://ip-science.thomsonreuters.com ), the wor...

2014-04-25 15:46 1070

Sinovac Receives Notification of China Government Grant for EV71 Vaccine Project

BEIJING, April 24, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading China-based vaccine manufacturer, announced today that it has received notification that a RMB 60 million free government grant has been approved by China's Ministry of Finance, National Development and Reform Comm...

2014-04-24 18:00 1365

International SOS Sees Increase in Demand for Malaria Advice

-- Requests for advice from travellers, expatriates and overseas workers up 27% since 2010 -- 11% of all International SOS medical cases attributed to infectious illnesses including malaria and dengue fever BEIJING, April 21, 2014 /PRNewswire/ -- International SOS has seen a 27% rise in the ...

2014-04-21 14:38 1275

Lilly and Novast Announce Ground Breaking of State of the Art Manufacturing Facility Expansion in Nantong, China

Opens a new chapter in their Strategic Partnership NANTONG, China, March 5, 2014 /PRNewswire/ -- Lilly and Novast Laboratories Ltd. (Novast), today announced that they have commenced the expansion of manufacturing and development facility capacities in Nantong, Jiangsu, China. The expansion is a ...

2014-03-05 13:48 2298

Lung Cancer Stage Four 10 Years Cancer-Free Through Non-toxic Alternative Cancer Treatment

-- Recurrent lung cancer responds to Integrative Immunotherapy SCOTTSDALE, Ariz., Feb. 11, 2014 /PRNewswire/ -- Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung cancer having the worst prognosis. In recent years the surge of immuno...

2014-02-11 23:07 1928

Sinovac Files Clinical Trial Application with CFDA for its Proprietary Vaccine against Avian Influenza A(H7N9) Virus

BEIJING, Jan. 29, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq:SVA), a leading provider of biopharmaceutical products in China, announced today that it has submitted a Clinical Trial Application(CTA) with the China Food and Drug Administration (CFDA) to commence human clinical trials for its va...

2014-01-29 20:07 1092

(RED), U2 and Bank of America Partner to Fight AIDS

-- Partnership will deliver more than $10 million to fight AIDS and launch with free download of new U2 song debuting during Super Bowl NEW YORK, Jan. 24, 2014 /PRNewswire/ -- (RED), rock group U2 and Bank of America today announced a partnership that will generate more than $10 million to fight AI...

2014-01-24 22:34 2105

Infinitus Promotes Healthy Life in Four Markets across Straits by Adopting Unique R&D System

HONG KONG, Dec. 30, 2013 /PRNewswire/ -- On 9 December, Academic Seminar for Hong Kong Traditional Chinese Medicine Research Centre (HKTCMRC) & Infinitus Scientific Advisory Board 2013 was held by Infinitus in Guangzhou. Principal Researcher of HKTCMRC Prof. Robert Ko and his research team from Hon...

2013-12-30 18:38 2539

Life Technologies' Food Pathogen Detection Methods Gains Approval by Australian Government

- Life Technologies' MicroSEQ(R) Real-Time PCR workflows approved as method for testing Australian export meat and meat products MELBOURNE, Australia, Dec. 16, 2013 /PRNewswire/ -- Life Technologies Corporation ( http://www.lifetech.com )(NASDAQ:LIFE) today announced that its MicroSEQ(R) Real-Tim...

2013-12-16 15:48 1449

Life Technologies' Food Pathogen Detection Methods Gains Approval by Australian Government

- Life Technologies' MicroSEQ® Real-Time PCR workflows approved as method for testing Australian export meat and meat products MELBOURNE, Australia, Dec 16, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ:LIFE) today announced that its MicroSEQ® Real-Time PCR workflow was officia...

2013-12-16 14:44 1497

Top International Hospitals to Hold Summit in Asia to Address Efficiency, Patient Safety Issues

World-renowned physicians, hospital managers and health ministries will join forces at the highly anticipated, Hospital Efficiency and Quality Asia Summit 2014 in Malaysia. SINGAPORE, Dec. 4, 2013 /PRNewswire/ -- Growing concern over patient safety is at the heart of every serious discussion amo...

2013-12-04 11:12 1360

Spending Time with Your Dog may Help Lower Your Blood Pressure

WALTHAM ON THE WOLDS, England, Dec. 2, 2013 /PRNewswire/ -- New research suggests the presence of pet dogs may help to control hypertension in older adults. The presence of a pet dog can significantly lower the blood pressure of its owner as they go about their day-to-day activities, new resea...

2013-12-02 22:00 1402

Daiichi Sankyo's Once-Daily Edoxaban Meets Primary Efficacy Endpoint for Stroke Prevention and Superiority for the Principal Safety Endpoint Compared to Warfarin for Patients with Atrial Fibrillation in a Phase 3 Clinical Trial

- Once-daily edoxaban, evaluated in two treatment arms (60 mg and 30 mg), achieved the primary endpoint of non-inferior efficacy versus warfarin in the prevention of stroke or systemic embolism - Rates of major bleeding were significantly reduced with edoxaban compared to warfarin - Efficacy a...

2013-11-20 01:09 1543
1 ... 37383940414243